Clinical Trial Detail

NCT ID NCT03188965
Title First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Bayer
Indications

diffuse large B-cell lymphoma

colorectal cancer

endometrial cancer

prostate cancer

non-Hodgkin lymphoma

ovarian cancer

cervical cancer

mantle cell lymphoma

lung cancer

Advanced Solid Tumor

Therapies

BAY1895344

Age Groups: adult senior

No variant requirements are available.